Advance in molecular diagnostic tools for hepatitis B virus detection

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 9, 2013, Pages 1707-1717

  Pazienza, Valerio ^a   Niro, Grazia Anna ^a   Fontana, Rosanna ^a   Vinciguerra, Manlio ^b   Andriulli, Angelo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biomolecular; Diagnosis; Hepatitis B virus (HBV)

Indexed keywords

DNA POLYMERASE; GENOMIC DNA; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; NUCLEIC ACID; NUCLEOCAPSID PROTEIN; VIRUS DNA;

AMPLICON; ANTIVIRAL THERAPY; CELL PROLIFERATION; DNA RNA HYBRIDIZATION; DNA VIRUS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENE OVEREXPRESSION; GENETIC VARIABILITY; HEPADNAVIRIDAE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIFE CYCLE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; OPEN READING FRAME; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; VIREMIA; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION;

DNA, VIRAL; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; VIRUS REPLICATION;

EID: 84888089487     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0136     Document Type: Review

References (57)

1. Zanetti AR. Update on hepatitis B vaccination in Italy 10 years after its implementation. Vaccine 2001;19: 2380-3. (Pubitemid 32234244)
2. Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C, et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine 2003;21: 685-91. (Pubitemid 36091979)
3. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology 1987;4: 758-63. (Pubitemid 17130717)
4. Ganem D, Schneider R. Hepadnaviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott-Raven, 2001: 2923-70.
5. Locarnini S. Molecular virology of hepatitis B virus. Semin Liver Dis 2004;24(Suppl 1): 3-10. (Pubitemid 38738352)
6. Masahiko K. The ultrastructural morphology of native hepatitis B virus. Med Mol Morphol 2006;39: 136-45.
7. Dryden KA. Native hepatitis B virions and capsids visualized by electron cryomicroscopy. Molecular Cell 2006;22: 843-50.
8. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res 2007;127: 164-76. (Pubitemid 47064411)
9. Howard CR. The biology of hepadnaviruses. J Gen Virol 1986;67: 1215-35.
10. Kramvis A, Kew M, François G. Hepatitis B virus genotypes. Vaccine 2005;19: 2409-23.
11. Delius H, Gough NM, Cameron CH, Murray K. Structure of the hepatitis B virus genome. J Virol 1983;47: 337-43. (Pubitemid 13074616)
12. Zuckerman A, Thomas H. Viral hepatitis. Edinburgh: Churchill Livingstone; 1993:84.
13. Beck J, Nassal M. Hepatitis B virus replication. World J Gastroenterol 2007;13: 48-64. (Pubitemid 46165462)
14. Chevaliez S, Pawlotsky JM. Virological tools in hepatitis b virus infection. Eur Infect Dis 2007;1: 58-60.
15. Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. J Virol 2004;78: 12725-34. (Pubitemid 39507781)
16. Guo Y, Kang W, Lei X, Li Y, Xiang A, Liu Y, et al. Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions. BMC Genomics. 2012;13:563. doi: 10.1186/1471- 2164-13-563.
17. Rosner MT. Hepatitis B virus X gene: a promiscuous transcriptional activator. J Med Virol 1992;36: 101-17.
18. Madden CR, Shagle BL. Stimulation of cellular proliferation by HBx protein. Dis Markers 2001;17: 153-7. (Pubitemid 34014692)
19. Thomas HC, Carman WF. The host immune response may be responsible for the selection of envelope and precore/core variants of HBV. Progress Liver Dis 1992;10: 239-51.
20. Chen RW, Sarna S, Lappalainen M. Real time PCR for detection and quantification of HBV DNA. J Med Virol 2001;65: 250-6. (Pubitemid 32816694)
21. Lin HJ, Lai C, Lauder IJ, Wu P, Lau TK, Fong MW. Application of hepatitis B virus (HBV) DNA sequence polymorphisms to the study of HBV transmission. J Infect Dis 1991;164: 284-8.
22. Sloan RD, Ljaz S, Moore PL, Harrison TJ, Teo CG, Tedder RS. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant. Antivir Ther 2008;13: 439-47. (Pubitemid 352016737)
23. Lim CK, Tan JT, Khoo JB, Ravichandran A, Low HM, Chan YC, et al. Correlations of HBV genotypes, mutations affecting HBeAg expression and HBeAg/anti-HBe status in HBV carriers. Int J Med Sci 2006;3: 14-20. (Pubitemid 43042125)
24. Gomes SA, Yoshima CF, Niel C. Detection of hepatitis B virus DNA in hepatitis B surface antigen negative serum PCR. Acta Virol 1996;40: 133-8.
25. Thiers V, Nakaima E, Krendorf D, Tiollas P, Brechot C. A transmission of hepatitis B virus from hepatitis B seronegative subject. Lancet 1998;94: 151-6.
26. Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991;163: 397-9.
27. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007;46: 160-70. (Pubitemid 44827430)
28. Degos F, Degott C, Tiollas P, Brechot C. Hepatitis B virus and hepatitis B related viral infection in renal transplant recipients. Gastroenterology 1998;94: 151-6.
29. Pollicino T, Saitta C, Raimondo G. Hepatocellular carcinoma: the point of view of the hepatitis B virus. Carcinogenesis 2011;32: 1122-32.
30. Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 2010;15: 14-22.
31. Paterlini P, Pousin K, Ken D, Brecot C. Selective accumulation of the X transcript of Hepatitis B virus in patients negative for hepatitis B surface antigen with HCC. Hepatology 2001;21: 313-21.
32. Liu H, Xu L, He H, Zhu Y, Liu J, Wang S, et al. Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein. Cancer Sci 2012;103: 2072-81.
33. Conjcevoram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001;34: 204-6. (Pubitemid 32591501)
34. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Villari D, de Franchis R, et al. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology 2000;31: 507-12. (Pubitemid 30078620)
35. Raimondo G, Balsano C, Craxì A, Farinati F, Levrero M, Mondelli M, et al. Occult hepatitis B virus infection. Dig Liver Dis 2000;32: 822-6. (Pubitemid 32098083)
36. Tong S, Kim KH, Chante C, Wands J, Li J. Hepatitis B virus e antigen variants. Int J Med Sci 2005;2: 2-7. (Pubitemid 40944952)
37. Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis 2005;37: 622-7. (Pubitemid 44356074)
38. Dai MS, Lu JJ, Chen YC, Chao TY. Reactivation of precore mutants hepatitis B virus in chemotherapy-treated patients. Cancer 2001;92: 1227-32.
39. Ho KN, Chan TM, Cheng KP. Comparison the second Dygene Hybrid capture assay with the branched DNA assay for measurement of HBV DNA in serum. J Clin Microb Rev 1999;12: 351-66.
40. Chung HT. Detection of HBV DNA in serum using a PCR-based assay. Methods Mol Med 2004;95: 15-20.
41. Izmirli S, Celik DG, Yuksel P, Saribas S, Aslan M, Ergin S, et al. The detection of occult HBV infection in patients with HBsAg negative pattern by real-time PCR method. Transfus Apher Sci 2012;43: 283-7.
42. Shreiber GB, Bush MP, Kleiman SH, Korelitz JJ. The risk of transfusion transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334: 1685-90.
43. Stramer SL, Caglioti S, Strong DM. NAT of the United States and Canadian blood supply. Transfusion 2000;40: 1165-8.
44. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003;46: 329-38. (Pubitemid 38037030)
45. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012;57: 167-85.
46. Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev 2007;20: 426-39. (Pubitemid 47175012)
47. Bartholomeusz A, Schaefer S. Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol 2004;14: 3-16. (Pubitemid 38133622)
48. Osiowy C. Sensitive detection of HBsAg mutants by a gap ligase chain reaction assay. J Clin Microbiol 2002;40: 2566-71. (Pubitemid 34747363)
49. Lindh M, Gonzalez JE, Norkrans G, Horal P. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods 1998;72: 163-74. (Pubitemid 28306959)
50. Teles SA, Martins RM, Vanderborght B, Stuyver L, Gaspar AM, Yoshida CF. Hepatitis B virus: genotypes and subtypes in Brasilia Hemodialysis patients. Artif Organs 1999;23: 1074-8. (Pubitemid 30021916)
51. Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 1999;450: 66-71. (Pubitemid 29206714)
52. Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 2001;39: 362-4. (Pubitemid 32059621)
53. Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, et al. Serological detection of hepatitis B virus genotypes by ESLISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 1999;80: 97-112. (Pubitemid 29248907)
54. Locarnini SA. Clinical relevance of viral dynamics and genotypes in hepatitis B virus. J Gastroenterol Hepatol 2002;17:S322-8. (Pubitemid 35454304)
55. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45: 507-39. (Pubitemid 46374607)
56. Hong SP, Kim NK, Hwang SG, Chung HJ, Kim S, Han JH, et al. Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. J Hepatol 2004;40: 837-44. (Pubitemid 38507366)
57. Stuyver L, Van Geyt C, De Gendt S, Van Reybroeck G, Zoulim F, Leroux-Roels G, et al. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol 2000;38: 702-7. (Pubitemid 30082666)